Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Gill currently holds 12,500 shares of Altimmune, Inc. (ALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Gill has been a net seller of ALT stock. They have purchased $55.6K and sold $141.1K worth of shares.
John Gill's most recent insider trade was on Dec 23, 2025, when they purchased 12,500 shares at $4.10 per share.
John Gill serves as Executive at Altimmune, Inc. (ALT). They have executed 18 insider transactions totaling $196.7K over their tenure at the company.
John Gill holds the position of Executive at Altimmune, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
John Gill has shown a selling trading pattern, with $55.6K in total purchases and $141.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Gill was on Nov 22, 2016, when they sold $220.0K worth of PIP shares. This transaction involved 100,000 shares at $2.20 per share.
John Gill currently owns 12,500 shares of Altimmune, Inc. (ALT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Gill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Gill has 18 Form 4 filings on record as an insider at Altimmune, Inc..
Set alerts for John Gill and 40,000+ other insiders.